Fuji’s Avigan Trials for Treatment of COVID-19 Prove Inconclusive
The optics industry has not rested on its laurels during the novel coronavirus outbreak, that’s for sure.
For one, both Canon and Fuji contributed pretty much from day one with Canon providing a testing kit it developed and Fuji’s drug subsidiary offering up its medicine called Avigan.
Also known as Favipiravir, Avigan was prescribed in the beginning of the outbreak as a potential treatment for the disease which, as of yet, has no vaccine or cure. This early success spurred on a wider testing of the drug, the importance of which even became a bit of a scandal for the Japanese Prime Minister when his government failed to meet their initial deadlines for testing the drug.
In fact, Shinzo Abe had hoped it would be approved for treatment in May yet that didn’t happen. And,…
This is only a snippet of a Photography Article written by Kehl Bayern
Read Full Article
This Content is Generated from RSS Feeds, if your content is featured and you would like to be removed, please Contact Us With your website address and name of site you wish to be removed from.
You can control what content is distributed in your RSS Feed by using your Website Editor.